M. G. Morgado

Prevention of HIV-1 Infection with Early Antiretroviral Therapy for the HPTN 052 Study Team*

Myron S. Cohen, Ying Qing Chen, Marybeth McCauley et al. · 2011 · 86 citations

Hptn 052, Early Antiretroviral Therapy, Treatment And Prevention +5

Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis

Valéria C. Rolla, María Aparecida Vieira, Douglas Pereira Pinto et al. · Clinical Drug Investigation · 2006 · 29 citations

Pulmonary Tuberculosis, Rifampicin Combined Therapy, Treatment And Prevention +10

Correlation between susceptibility of primary HIV-1 isolates to autologous and heterologous neutralizing antibodies

Vera Bongertz, Catia Inês Costa, Valdiléa Gonçalves Veloso dos Santos et al. · AIDS · 1997 · 11 citations

Trypanosoma cruzi: identification of specific epimastigote antigens by human immune sera

M. G. Morgado, J. Ivo-dos-Santos, Rosa T. Pinho et al. · Memórias do Instituto Oswaldo Cruz · 1989 · 10 citations · Full text

Trypanosoma Cruzi, Soluble Antigens, Parasitic Disease +14